PRENATAL TEST KITS DETERMINING

Brand	Owner	Address	Description
MATERNIT21	SEQUENOM, INC.	3595 John Hopkins Court San Diego CA 92121	prenatal test kits for determining fetal chromosomal abnormalities; diagnostic reagents, preparations and test kits for medical purposes; chemical reagents, preparations and test kits for nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid analysis and for detecting genetic conditions, disorders and diseases for medical use;MATERNITY 21;nucleic acid based test kits for determining fetal chromosomal abnormalities for laboratory or research use; diagnostic reagents, preparations and test kits for scientific or clinical purposes;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

This invention is about a method for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic reagent system and diagnostic kit for the diagnosis. The method, diagnostic reagent system, and kit are based on the finding that the level of MMP-8 in the amniotic fluid is significantly higher when the pregnant woman is at risk for preterm delivery, intrauterine infection, and fetal damage. The diagnostic reagent system and kit can be applied to patients with or without clinical signs of preterm labor or premature rupture of fetal membranes. With its superiority in sensitivity and specificity as well as its less invasiveness compared to the conventional method of measuring fetal blood cytokine levels, this diagnostic reagent system and kit is very useful in the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage.